UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.68 +0.66 (+0.85%) GOLD FUTURES
2,393.60 +33.70 (+1.43%) DOW
39,836.47 +278.36 (+0.70%) Bitcoin GBP
51,605.07 +3,245.21 (+6.71%)
Apyx Medical Corporation (APYX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:20PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 48.85M |
| Enterprise value | 50.19M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.97 |
| Price/book (mrq) | 2.41 |
| Enterprise value/revenue | 0.99 |
| Enterprise value/EBITDA | -5.33 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -76.26% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 7.9700 |
| 52-week low 3 | 1.2100 |
| 50-day moving average 3 | 1.5149 |
| 200-day moving average 3 | 2.5898 |
Share statistics
| Avg vol (3-month) 3 | 156.84k |
| Avg vol (10-day) 3 | 89.21k |
| Shares outstanding 5 | 34.64M |
| Implied shares outstanding 6 | 35.14M |
| Float 8 | 24.98M |
| % held by insiders 1 | 17.92% |
| % held by institutions 1 | 46.51% |
| Shares short (30 Apr 2024) 4 | 540.34k |
| Short ratio (30 Apr 2024) 4 | 6.27 |
| Short % of float (30 Apr 2024) 4 | 1.62% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.56% |
| Shares short (prior month 28 Mar 2024) 4 | 706.67k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -45.20% |
| Operating margin (ttm) | -64.57% |
Management effectiveness
| Return on assets (ttm) | -20.30% |
| Return on equity (ttm) | -80.84% |
Income statement
| Revenue (ttm) | 50.45M |
| Revenue per share (ttm) | 1.46 |
| Quarterly revenue growth (yoy) | -15.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -20.04M |
| Net income avi to common (ttm) | -22.81M |
| Diluted EPS (ttm) | -0.6600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 37.28M |
| Total cash per share (mrq) | 1.08 |
| Total debt (mrq) | 38.62M |
| Total debt/equity (mrq) | 188.78% |
| Current ratio (mrq) | 5.87 |
| Book value per share (mrq) | 0.58 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.